These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 34259373)

  • 21. Sodium accumulation is associated with disability and a progressive course in multiple sclerosis.
    Paling D; Solanky BS; Riemer F; Tozer DJ; Wheeler-Kingshott CA; Kapoor R; Golay X; Miller DH
    Brain; 2013 Jul; 136(Pt 7):2305-17. PubMed ID: 23801742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Unenhanced and Gadolinium-Enhanced Imaging in Multiple Sclerosis: Is Contrast Needed for Routine Follow-Up MRI?
    Sadigh G; Saindane AM; Waldman AD; Lava NS; Hu R
    AJNR Am J Neuroradiol; 2019 Sep; 40(9):1476-1480. PubMed ID: 31439627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Manual Segmentation of MS Cortical Lesions Using MRI: A Comparison of 3 MRI Reading Protocols.
    Maranzano J; Rudko DA; Arnold DL; Narayanan S
    AJNR Am J Neuroradiol; 2016 Sep; 37(9):1623-8. PubMed ID: 27197988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis.
    Granberg T; Fan Q; Treaba CA; Ouellette R; Herranz E; Mangeat G; Louapre C; Cohen-Adad J; Klawiter EC; Sloane JA; Mainero C
    Brain; 2017 Nov; 140(11):2912-2926. PubMed ID: 29053798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accuracy of Unenhanced MRI in the Detection of New Brain Lesions in Multiple Sclerosis.
    Eichinger P; Schön S; Pongratz V; Wiestler H; Zhang H; Bussas M; Hoshi MM; Kirschke J; Berthele A; Zimmer C; Hemmer B; Mühlau M; Wiestler B
    Radiology; 2019 May; 291(2):429-435. PubMed ID: 30860448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cortical grey matter sodium accumulation is associated with disability and secondary progressive disease course in relapse-onset multiple sclerosis.
    Brownlee WJ; Solanky B; Prados F; Yiannakas M; Da Mota P; Riemer F; Cardoso MJ; Ourselin S; Golay X; Gandini Wheeler-Kingshott C; Ciccarelli O
    J Neurol Neurosurg Psychiatry; 2019 Jul; 90(7):755-760. PubMed ID: 30948625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Relevance of Multiparametric MRI Assessment of Cervical Cord Damage in Multiple Sclerosis.
    Bonacchi R; Pagani E; Meani A; Cacciaguerra L; Preziosa P; De Meo E; Filippi M; Rocca MA
    Radiology; 2020 Sep; 296(3):605-615. PubMed ID: 32573387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing lesion detection of infratentorial multiple sclerosis lesions between T2-weighted spin-echo, 2D-FLAIR, and 3D-FLAIR sequences.
    Wang KY; Uribe TA; Lincoln CM
    Clin Imaging; 2018; 51():229-234. PubMed ID: 29879598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study.
    Oreja-Guevara C; Rovaris M; Iannucci G; Valsasina P; Caputo D; Cavarretta R; Sormani MP; Ferrante P; Comi G; Filippi M
    Arch Neurol; 2005 Apr; 62(4):578-84. PubMed ID: 15824256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single scan quantitative gradient recalled echo MRI for evaluation of tissue damage in lesions and normal appearing gray and white matter in multiple sclerosis.
    Xiang B; Wen J; Cross AH; Yablonskiy DA
    J Magn Reson Imaging; 2019 Feb; 49(2):487-498. PubMed ID: 30155934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular imaging of the prostate: Comparing total sodium concentration quantification in prostate cancer and normal tissue using dedicated
    Barrett T; Riemer F; McLean MA; Kaggie JD; Robb F; Warren AY; Graves MJ; Gallagher FA
    J Magn Reson Imaging; 2020 Jan; 51(1):90-97. PubMed ID: 31081564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution of brain sodium accumulation correlates with disability in multiple sclerosis: a cross-sectional 23Na MR imaging study.
    Zaaraoui W; Konstandin S; Audoin B; Nagel AM; Rico A; Malikova I; Soulier E; Viout P; Confort-Gouny S; Cozzone PJ; Pelletier J; Schad LR; Ranjeva JP
    Radiology; 2012 Sep; 264(3):859-67. PubMed ID: 22807483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence of progressive tissue loss in the core of chronic MS lesions: A longitudinal DTI study.
    Klistorner A; Wang C; Yiannikas C; Parratt J; Dwyer M; Barton J; Graham SL; You Y; Liu S; Barnett MH
    Neuroimage Clin; 2018; 17():1028-1035. PubMed ID: 29387524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T1- Thresholds in Black Holes Increase Clinical-Radiological Correlation in Multiple Sclerosis Patients.
    Thaler C; Faizy T; Sedlacik J; Holst B; Stellmann JP; Young KL; Heesen C; Fiehler J; Siemonsen S
    PLoS One; 2015; 10(12):e0144693. PubMed ID: 26659852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histogram analysis of quantitative T1 and MT maps from ultrahigh field MRI in clinically isolated syndrome and relapsing-remitting multiple sclerosis.
    Al-Radaideh A; Mougin OE; Lim SY; Chou IJ; Constantinescu CS; Gowland P
    NMR Biomed; 2015 Nov; 28(11):1374-82. PubMed ID: 26346925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Choroid Plexus Enlargement in Inflammatory Multiple Sclerosis: 3.0-T MRI and Translocator Protein PET Evaluation.
    Ricigliano VAG; Morena E; Colombi A; Tonietto M; Hamzaoui M; Poirion E; Bottlaender M; Gervais P; Louapre C; Bodini B; Stankoff B
    Radiology; 2021 Oct; 301(1):166-177. PubMed ID: 34254858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
    Eijlers AJC; van Geest Q; Dekker I; Steenwijk MD; Meijer KA; Hulst HE; Barkhof F; Uitdehaag BMJ; Schoonheim MM; Geurts JJG
    Brain; 2018 Sep; 141(9):2605-2618. PubMed ID: 30169585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient-specific 3D FLAIR for enhanced visualization of brain white matter lesions in multiple sclerosis.
    Gabr RE; Pednekar AS; Govindarajan KA; Sun X; Riascos RF; Ramírez MG; Hasan KM; Lincoln JA; Nelson F; Wolinsky JS; Narayana PA
    J Magn Reson Imaging; 2017 Aug; 46(2):557-564. PubMed ID: 27869333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered signal intensity of active enhancing inflammatory lesions using post-contrast double inversion recovery MR sequence.
    Hodel J; Badr S; Outteryck O; Lebert P; Chechin D; Benadjaoud MA; Pruvo JP; Vermersch P; Leclerc X
    Eur Radiol; 2017 Feb; 27(2):637-641. PubMed ID: 27229340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis Patients.
    Todea AR; Melie-Garcia L; Barakovic M; Cagol A; Rahmanzadeh R; Galbusera R; Lu PJ; Weigel M; Ruberte E; Radue EW; Schaedelin S; Benkert P; Oezguer Y; Sinnecker T; Müller S; Achtnichts L; Vehoff J; Disanto G; Findling O; Chan A; Salmen A; Pot C; Lalive P; Bridel C; Zecca C; Derfuss T; Remonda L; Wagner F; Vargas M; Du Pasquier R; Pravata E; Weber J; Gobbi C; Leppert D; Wuerfel J; Kober T; Marechal B; Corredor-Jerez R; Psychogios M; Lieb J; Kappos L; Cuadra MB; Kuhle J; Granziera C;
    J Magn Reson Imaging; 2023 Sep; 58(3):864-876. PubMed ID: 36708267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.